Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02134288 · ClinicalTrials.gov registry record · Early Phase 1
Belatacept for Renal Transplant Recipients With Delayed Graft Function
A Early Phase 1 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT02134288: Clinical Trial Early Phase 1 study, sponsored by Ohio State University.
NCT02134288 is a Early Phase 1 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02134288, a Early Phase 1 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Currently looking for individuals that have received a kidney transplant, are experiencing delayed graft function (DGF), and meet the criteria for study participation.
Primary Outcome
For renal transplant recipients with DGF, time (days) to recover from DGF as defined as: date of enrollment (day 1) until calculated MDRD IV eGFR at least 21 ml/min: at least 2 days after last dialysis if meeting dialysis criteria for enrollment (end date) and no requirement for dialysis at least 2 weeks, with a stable or improving MDRD calculated eGFR (assessed weekly for at least three weeks).
Interventions
- DRUG Everolimus
- DRUG Belatacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-01-18 |
| Phase | Early Phase 1 |
Why NCT02134288 stopped before completion
NCT02134288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Everolimus is the first listed.
NCT02134288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02134288 about?
NCT02134288 is a clinical study titled "Belatacept for Renal Transplant Recipients With Delayed Graft Function". Currently looking for individuals that have received a kidney transplant, are experiencing delayed graft function (DGF), and meet the criteria for study participation.
What is the current status of trial NCT02134288?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2014-04. Estimated completion is 2019-01-18.
What interventions are being tested in trial NCT02134288?
The interventions under investigation include: Everolimus (DRUG), Belatacept (DRUG).
Who is sponsoring clinical trial NCT02134288?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02134288's enrollment target sits among peer trials
8 1782nd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia